1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > General Medicine and Specialty Medicine Analysis & Statistics, July 2015 (p7)

General Medicine and Specialty Medicine Analysis & Statistics, July 2015 (p7)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

181-210 of about 3 800 reports

Purchase Reports From Reputable Market Research Publishers

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2015

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • July 2015
  • by Global Markets Direct

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015’, provides an overview of the AIDS - Related ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Charcot-Marie-Tooth Disease - Pipeline Review, H2 2015

Charcot-Marie-Tooth Disease - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • July 2015
  • by Global Markets Direct

Charcot-Marie-Tooth Disease - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease - Pipeline Review, H2 2015’, provides an overview of the Charcot-Marie-Tooth Disease’s ...

  • Industries : Pathology
  • Countries : United States
Anaplastic Thyroid Cancer - Pipeline Review, H2 2015

Anaplastic Thyroid Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • July 2015
  • by Global Markets Direct

Anaplastic Thyroid Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Anaplastic Thyroid Cancer - Pipeline Review, H2 2015’, provides an overview of the Anaplastic Thyroid Cancer’s ...

  • Industries : Pathology
  • Countries : United States
Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2015

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • July 2015
  • by Global Markets Direct

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2015’, provides an overview of the Proliferative ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • July 2015
  • by Global Markets Direct

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015’, provides ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Blepharitis - Pipeline Review, H2 2015

Blepharitis - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • July 2015
  • by Global Markets Direct

Blepharitis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Blepharitis - Pipeline Review, H2 2015’, provides an overview of the Blepharitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2015

Age Related Macular Degeneration - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2015’, provides an overview of the Age Related ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Hepatocellular Carcinoma - Pipeline Review, H1 2015

Hepatocellular Carcinoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Hepatocellular Carcinoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Hypertension - Pipeline Review, H1 2015

Hypertension - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Hypertension - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Metastatic Colorectal Cancer - Pipeline Review, H1 2015

Metastatic Colorectal Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Metastatic Colorectal Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Kidney Cancer - Pipeline Review, H1 2015

Kidney Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Kidney Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline. This report ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Metastatic Breast Cancer - Pipeline Review, H1 2015

Metastatic Breast Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Metastatic Breast Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Colon Cancer - Pipeline Review, H1 2015

Colon Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Colon Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015’, ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Ischemia - Pipeline Review, H1 2015

Ischemia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Ischemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ischemia - Pipeline Review, H1 2015’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Cervical Cancer - Pipeline Review, H1 2015

Cervical Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Cervical Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2015’, provides an overview of the Cervical Cancer’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Neuroblastoma - Pipeline Review, H1 2015

Neuroblastoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2015’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Wounds - Pipeline Review, H1 2015

Wounds - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Wounds - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Wounds - Pipeline Review, H1 2015’, provides an overview of the Wounds’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Over-The-Counter Drug
  • Countries : United States
Myelodysplastic Syndrome - Pipeline Review, H1 2015

Myelodysplastic Syndrome - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Bladder Cancer - Pipeline Review, H1 2015

Bladder Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Bladder Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Atherosclerosis - Pipeline Review, H1 2015

Atherosclerosis - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Atherosclerosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Atherosclerosis - Pipeline Review, H1 2015’, provides an overview of the Atherosclerosis’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Ischemia Reperfusion Injury - Pipeline Review, H1 2015

Ischemia Reperfusion Injury - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Ischemia Reperfusion Injury - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ischemia Reperfusion Injury - Pipeline Review, H1 2015’, provides an overview of the Ischemia Reperfusion ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Thrombocytopenia - Pipeline Review, H1 2015

Thrombocytopenia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Thrombocytopenia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2015’, provides an overview of the Thrombocytopenia’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Migraine - Pipeline Review, H1 2015

Migraine - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Migraine - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2015’, provides an overview of the Migraine’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.